- AbbVie’s $63 Billion MistakeMotley Fool
- AbbVie looks beyond Humira with a $63 billion deal for Botox-maker AllerganCNBC
- AbbVie Strikes Deal to Buy Allergan for About $63 BillionThe Wall Street Journal
- Botox Maker Allergan Is Sold to AbbVie in $63 Billion DealThe New York Times
- Allergan stock surges on news that Abbvie will buy Botox maker in a $63 billion dealYahoo Finance
- View full coverage on Google News